| Patricia Reber, Do | |
|
9705 State Route 267 Ste 1 Truckee CA 96161-0370 | |
| (530) 213-5606 | |
| (650) 446-1039 |
| Full Name | Patricia Reber, Do |
|---|---|
| Speciality | Clinic/center |
| Location | 9705 State Route 267 Ste 1, Truckee, California |
| Authorized Official Name and Position | Patricia Reber (CEO) |
| Authorized Official Contact | 5302135606 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Reber, Do Po Box 995 Truckee CA 96160-0995 Ph: (530) 213-5606 | Patricia Reber, Do 9705 State Route 267 Ste 1 Truckee CA 96161-0370 Ph: (530) 213-5606 |
| NPI Number | 1356801203 |
|---|---|
| Provider Enumeration Date | 03/25/2019 |
| Last Update Date | 03/25/2019 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356801203 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
News Archive
Fluidigm Corporation announced today a collaboration with BD Biosciences, a segment of BD, to co-host a public seminar series on the isolation and analysis of single cells. Entitled A Powerful Technique for Single-Cell Analysis, the public seminar series will showcase cell isolation using the BD FACSAria III Cell Sorter and analysis using the Fluidigm BioMark HD System.
American Dental Partners, Inc. (NASDAQ: ADPI) announced today that it completed its previously announced public offering of 2,260,000 shares of common stock at a price of $12.00 per share to the public (excluding the underwriter's over-allotment option to purchase an additional 339,000 shares) with net proceeds of approximately $25,300,000 after deducting underwriting discounts and commissions and estimated expenses of the offering.
Patients with advanced chronic kidney disease (CKD) often do not receive adequate end-of-life care and are unhappy with the medical decisions made as their conditions worsen, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that end-of-life care should be improved to meet the needs of CKD patients.
The Food and Health Bureau has invited expressions of interest (EOI) from Hong Kong and overseas parties in developing private hospitals at four sites in the Hong Kong Special Administrative Region.
Abraxis BioScience, Inc. announced today that findings from their phase 3 randomized trial of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) plus carboplatin, showed a statistically significant 31 percent improvement in overall response rate when compared with Taxol (paclitaxel) injection plus carboplatin in the first-line treatment of patients with non-small cell lung cancer.
› Verified 5 days ago
Tahoe Forest Hospital District Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10956 Donner Pass Rd Ste 110, Truckee, CA 96161 Phone: 530-581-8864 | |
Donner Pass Medical Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10956 Donner Pass Rd, Suite 260, Truckee, CA 96161 Phone: 530-582-6400 Fax: 530-582-6991 | |
Tahoe Forest Msc Im/card Rhc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 10978 Donner Pass Rd, Truckee, CA 96161 Phone: 530-582-1212 | |
Tahoe Forest Multispecialty Clinics Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 10956 Donner Pass Rd, Suite 130, Truckee, CA 96161 Phone: 530-587-3523 | |
Sierra Cosmetic Laser, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10448 Donner Pass Rd, Truckee, CA 96161 Phone: 530-448-6207 | |
Tahoe Forest Multispecialty Clinic Ob Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10175 Levone Ave, Truckee, CA 96161 Phone: 530-587-1041 |